Skip Navigation

Cover Image
Other Issues:
Previous Next 		Contents: Volume 8, Suppl F : October 2006   [Index by Author] 
      Down Preface
      Down Guest editorial
      Down Articles

 
 
Proceedings of the 2nd International Merck Symposium on HDL-C Raising, Bridging the gap in cardiovascular risk reduction: A call to action, Barcelona, 14-15 October, 2005

The symposium and these proceedings were made possible by an unrestricted educational grant from Merck KGaA, Germany

Edited by H. Ilkova (Turkey), T.R. Pedersen (Norway), J. Shepherd (United Kingdom)
 


[Search ALL Issues]

Table of Contents (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Preface:Back

Francisco Fernández-Avilés
Preface
Eur Heart J Suppl 2006; 8: F1. [Extract] [Full Text] [PDF]  

Guest editorial:Back

Hasan Ilkova, Terje R. Pedersen, and James Shepherd
Guest editorial
Eur Heart J Suppl 2006; 8: F3. [Extract] [Full Text] [PDF]  

Articles:Back

Cesare R. Sirtori
HDL and the progression of atherosclerosis: new insights
Eur Heart J Suppl 2006; 8: F4-F9. [Abstract] [Full Text] [PDF]  

Terje R. Pedersen
The gap between theory and practice: what do the trials tell us?
Eur Heart J Suppl 2006; 8: F10-F16. [Abstract] [Full Text] [PDF]  

Eric Bruckert
Epidemiology of low HDL-cholesterol: results of studies and surveys
Eur Heart J Suppl 2006; 8: F17-F22. [Abstract] [Full Text] [PDF]  

Heinz Drexel
Reducing risk by raising HDL-cholesterol: the evidence
Eur Heart J Suppl 2006; 8: F23-F29. [Abstract] [Full Text] [PDF]  

Anthony S. Wierzbicki
Diabetic dyslipidaemia: the triad
Eur Heart J Suppl 2006; 8: F30-F33. [Abstract] [Full Text] [PDF]  

Diethelm Tschoepe and Bernd Stratmann
Plaque stability and plaque regression: new insights
Eur Heart J Suppl 2006; 8: F34-F39. [Abstract] [Full Text] [PDF]  

Gerd Assmann
Dyslipidaemia and global cardiovascular risk: clinical issues
Eur Heart J Suppl 2006; 8: F40-F46. [Abstract] [Full Text] [PDF]  

Philip Barter
Options for therapeutic intervention: how effective are the different agents?
Eur Heart J Suppl 2006; 8: F47-F53. [Abstract] [Full Text] [PDF]  

M. John Chapman
How does nicotinic acid modify the lipid profile?
Eur Heart J Suppl 2006; 8: F54-F59. [Abstract] [Full Text] [PDF]  

B. Greg Brown
Niaspan® in the management of dyslipidaemia: the evidence
Eur Heart J Suppl 2006; 8: F60-F67. [Abstract] [Full Text] [PDF]  

Charles A. Reasner
Achieving the therapeutic benefits of Niaspan® in daily practice
Eur Heart J Suppl 2006; 8: F68-F73. [Abstract] [Full Text] [PDF]  

Allen J. Taylor
Evidence to support aggressive management of HDL-cholesterol: implications of recent trials
Eur Heart J Suppl 2006; 8: F74-F80. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.